NCT07089420View on ClinicalTrials.gov

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
IBD (Inflammatory Bowel Disease)IBS - Irritable Bowel SyndromeCrohn Disease (CD)UC - Ulcerative Colitis
Interventions
DEVICE

ALPCO Calprotectin CLIA

Measurement of calprotectin in feces

Trial Locations (1)

03079

RECRUITING

ALPCO, Salem

Sponsors
All Listed Sponsors
lead

American Laboratory Products Company

INDUSTRY